Yearly Injection To Protect Against HIV? Gilead's Lenacapavir Shows Promise In Clinical Trial
A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...
El Mundo on MSN54m
New advance against HIV: a single annual injection against the infection
Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...